Psychemedics Corporation Receivables Turnover Ratio (PMD), from the fourth quarter 2024 to the fourth quarter 2023 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Psychemedics Corporation  (PMD)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Psychemedics Accounts Receivables Turnover Ratio from the fourth quarter 2024 to the fourth quarter 2023

Quarterly Results, Trends, Rankings, Statistics


Psychemedics Corporation's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2024 to a ratio of 5.98, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the fourth quarter 2024. Average receivable collection period, for the Psychemedics in Dec 31 2024 quarter, has decreased to 61 days, compared to 63 days, in the Sep 30 2024 quarter.

If we take a look into Healthcare sector 23 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 224, from overall ranking in the third quarter 2024 at 2254.

What is Receivable Turnover Ratio?
What is Psychemedics Corporation Selling?


What is Receivable Turnover Ratio?





PMD Receivables Turnover Ratio (Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
Y / Y Receivable Change -32.19 % -27.65 % -23.57 % -4.31 % -1.39 %
Y / Y Revenue Change -18.8 % -1.02 % -10.02 % -12.58 % -5.24 %
Receivable Turnover Ratio (TTM) 5.98 5.77 5.3 5.12 5.24
PMD's Total Ranking # 224 # 2254 # 285 # 1963 # 1875
Accounts Receivable average collection period days 61 63 69 71 70
Seq. Receivable Change -24.81 % 8.73 % -21.25 % 5.32 % -19.78 %
Seq. Revenue Change -12.92 % 10.7 % -11.13 % -5.22 % 6.15 %


Receivable Turnover Company Ranking
Within: No.
Medical Laboratories Industry # 1
Healthcare Sector # 24
Overall Market # 224

Receivable Turnover Ratio Statistics
High Average Low
1.94 1.39 0.8
(Dec 31 2024)   (Mar 31 2021)






Financial Statements
Psychemedics's Accounts Receivable $ 3 Millions Visit PMD's Balance sheet
Psychemedics's Sales TTM $ 19 Millions Visit PMD's Income Statement
Sources of PMD's Revenues Visit PMD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PMD's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PMD's Growth Rates PMD's Roa PMD's Inventory Turnover Ratio PMD's Dividend Comparisons
PMD's Profitability Ratios PMD's Roi PMD's Asset Turnover Ratio PMD's Dividend Growth
PMD's Valuation Ratios PMD's Roe PMD's Financial Strength Ratios PMD's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2024 Receivable at quarter ending Dec 31 2024
Neuraxis Inc   20.09 $ 2.686  Millions$ 0.134  Millions
Ontrak Inc   19.43 $ 10.824  Millions$ 0.557  Millions
Precipio inc   19.34 $ 18.532  Millions$ 0.958  Millions
Valion Bio Inc   18.57 $ 0.780  Millions$ 0.042  Millions
Silence Therapeutics Plc  17.91 $ 43.258  Millions$ 2.416  Millions
Talkspace Inc   17.86 $ 186.836  Millions$ 10.459  Millions
Vireo Growth Inc.  17.37 $ 99.384  Millions$ 5.721  Millions
Generation Bio Co   16.67 $ 19.892  Millions$ 1.193  Millions
Innovage Holding Corp   16.60 $ 806.613  Millions$ 48.590  Millions
Kiniksa Pharmaceuticals International Plc  16.43 $ 423.239  Millions$ 25.764  Millions
Milestone Scientific Inc   16.26 $ 8.435  Millions$ 0.519  Millions
Gsk Plc  16.16 $ 31,376.000  Millions$ 1,942.000  Millions
Hookipa Pharma inc   16.12 $ 43.946  Millions$ 2.727  Millions
Voyager Therapeutics Inc   16.00 $ 80.001  Millions$ 4.999  Millions
Stablecoin Development Corporation  15.97 $ 9.481  Millions$ 0.594  Millions
Petvivo Holdings Inc   15.73 $ 0.956  Millions$ 0.061  Millions
Mannkind Corporation  15.59 $ 285.504  Millions$ 18.312  Millions
Medinotec Inc   15.50 $ 8.947  Millions$ 0.577  Millions
Nexalin Technology Inc   15.48 $ 0.169  Millions$ 0.011  Millions
Cervomed Inc   15.47 $ 9.738  Millions$ 0.630  Millions
Waters Corporation  15.20 $ 2,958.387  Millions$ 194.592  Millions
Biofrontera Inc   14.59 $ 63.395  Millions$ 4.346  Millions
Icu Medical Inc  14.57 $ 2,382.046  Millions$ 163.441  Millions
Sangamo Therapeutics Inc   14.13 $ 57.800  Millions$ 4.092  Millions
Inmed Pharmaceuticals Inc  14.12 $ 4.494  Millions$ 0.318  Millions
China Pharma Holdings Inc  13.76 $ 4.529  Millions$ 0.329  Millions
Chemed Corporation  13.32 $ 2,431.287  Millions$ 182.485  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  13.23 $ 4.879  Millions$ 0.369  Millions
Amylyx Pharmaceuticals Inc   13.13 $ 87.371  Millions$ 6.655  Millions
Patterson Companies Inc   13.08 $ 6,511.680  Millions$ 497.898  Millions

Date modified: 2026-06-22T11:02:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.